Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS-9450 in Adults With Chronic Hepatitis C Virus Infection
NCT00874796Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- May 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of nivocasan in hepatitis C (HCV), sponsored by Gilead Sciences. Started May 2009; status: terminated.
02
Drugs
nivocasan
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00874796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874796.